Abstract
You have accessJournal of UrologyProstate Cancer: Epidemiology & Natural History II1 Apr 2017MP14-07 EFFECT OF HYPOGONADISM ON PROSTATE IMAGING AND CANCER DETECTION Dordaneh Sugano, Abhinav Sidana, Brian Calio, Sonia Gaur, Mahir Maruf, Amit L. Jain, Maria Merino, Peter Choyke, Baris Turkbey, Bradford J. Wood, and Peter A. Pinto Dordaneh SuganoDordaneh Sugano More articles by this author , Abhinav SidanaAbhinav Sidana More articles by this author , Brian CalioBrian Calio More articles by this author , Sonia GaurSonia Gaur More articles by this author , Mahir MarufMahir Maruf More articles by this author , Amit L. JainAmit L. Jain More articles by this author , Maria MerinoMaria Merino More articles by this author , Peter ChoykePeter Choyke More articles by this author , Baris TurkbeyBaris Turkbey More articles by this author , Bradford J. WoodBradford J. Wood More articles by this author , and Peter A. PintoPeter A. Pinto More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2017.02.471AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Previous studies have demonstrated hypogonadism to be associated with higher grade prostate cancer (PCa) on prostate biopsy. However, there is a lack of literature on how hypogonadism (HG) affects prostate imaging on multiparametric MRI (mpMRI). Here, we aim to determine the impact of hypogonadism on PCa detection on MRI and subsequent detection on MRI-TRUS fusion biopsy (FBx). METHODS Clinical and pathologic data from a prospectively maintained, single-institution database were analyzed for patients who underwent FBx and standard biopsy (SBx) between 2007 and 2016. Patients with total testosterone (TT) measured within 90 days of mpMRI were included in the study. Patients were excluded if they received prior radiation or androgen deprivation therapy for prostate cancer. HG was determined by a TT level below 180 ng/dL. T2, DWI, and DCE scores were calculated from mpMRI and analyzed as binary variables. RESULTS In our cohort, 522 patients had testosterone measured within 90 days of mpMRI, of which 80 (15.3%) were deemed to be HG. Compared to normogonadal (NG) patients, HG patients had comparable age (62.0 years, IQR 8.8 vs 65.0 years, IQR 10.0; p = 0.519) and PSA (6.66 ng/ml, IQR 6.38 vs 6.86 ng/ml IQR 5.33; p=0.523). Median TT was 171 ng/dL (IQR 46) in the HG cohort, and 311 ng/dL (IQR 131) in the NG cohort (p<0.001). Imaging results were not significantly different between the HG and NG cohorts: prostate volume on MRI was 49.5 cc (IQR 40) vs. 50.0 cc (IQR 33), p=0.621; DWI was 95.0% vs 93.2% positive, p=0.542; DCE was 96.3% vs 91.4% positive, p=0.136. There was a lower detection rate of clinically significant cancer on SBx in the HG group compared to the NG group (28.8% vs 37.2%). However, FBx detection rates were similar between the HG and NG cohorts (40.4% vs 43.6%). In our cohort, 78 patients underwent radical prostatectomy. Of these, HG patients had higher rates of positive margins, lymph node invasion, seminal vesical invasion and Gleason score upgrade on pathology (22.2% vs 14.9%, 11.1% vs 7.5%, 11.1% vs 6.0%, and 22.2% vs 12.5%). CONCLUSIONS While SBx cancer detection rate (CDR) was lower in HG patients, FBx CDR was comparable in HG and NG cohorts, suggesting that FBx may provide an advantage in HG patients. In addition, HG patients seem to have higher adverse pathologic criteria in our MRI-screened cohort. Future larger, multi-institutional studies will be necessary to fully ascertain the impact of HG on PCa detection and staging by mpMRI. © 2017FiguresReferencesRelatedDetails Volume 197Issue 4SApril 2017Page: e164 Advertisement Copyright & Permissions© 2017MetricsAuthor Information Dordaneh Sugano More articles by this author Abhinav Sidana More articles by this author Brian Calio More articles by this author Sonia Gaur More articles by this author Mahir Maruf More articles by this author Amit L. Jain More articles by this author Maria Merino More articles by this author Peter Choyke More articles by this author Baris Turkbey More articles by this author Bradford J. Wood More articles by this author Peter A. Pinto More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.